ArticleRetrovirology2010

In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy.

Tanya Lynn Applegate et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.